Ulimorelin Study of Efficacy and Safety (ULISES 008)

Completed · Phase 3 · Has a placebo group

Conditions studied: Gastrointestinal Dysmotility

In brief

Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection

Key facts

Study ID
NCT01296620
Run by
Tranzyme, Inc.
People needed
330
Starts
2011-02-01
Expected to finish
2012-03-01
Last updated by the study team
2012-07-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.